Hospital San Carlos, Madrid

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Employees: 5K

Market Cap: -

Website

Clinical Trials

Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient

Conditions: Morbid Obesity

First Posted Date: 2012-09-14

Last Posted Date: 2012-09-14

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 30

Registration Number: NCT01685177

Locations: 🇪🇸
Hospital Clínico San Carlos, Madrid, Spain

Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications

Conditions: Morbid Obesity
Diabetes

Interventions: Procedure: SADI-S 250

First Posted Date: 2011-11-02

Last Posted Date: 2011-11-02

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 250

Registration Number: NCT01463904

Locations: 🇪🇸
Hospital Clínico San Carlos, Madrid, Spain

Cryoenergy Or Radiofrequency for Pulmonary Vein Isolation

Phase 4

Completed

Conditions: Atrial Fibrillation

Interventions: Device: Pulmonary vein cryoablation
Device: Pulmonary vein radiofrequency ablation

First Posted Date: 2009-09-01

Last Posted Date: 2013-04-04

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 50

Registration Number: NCT00969735

Locations: 🇪🇸
Unidad de Arritmias, Hospital Clínico San Carlos, Madrid, Spain

Sirolimus-Eluting Stent Versus Standard Stent in Diabetic

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Device: Bare metal stent
Device: Drug eluting stent

First Posted Date: 2008-09-19

Last Posted Date: 2008-09-19

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 160

Registration Number: NCT00755443

Locations: 🇪🇸
Hospital Clinico San carlos, Madrid, Spain

Compact Closed System Versus Mounted Open System (COSMOS)

Phase 4

Completed

Conditions: Catheterization, Peripheral

Interventions: Device: Closed Intravenous System - Nexiva®
Device: Open Intravenous System - Vasocan®

First Posted Date: 2008-04-24

Last Posted Date: 2009-04-13

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 1200

Registration Number: NCT00665886

Locations: 🇪🇸
Hospital Clínico San Carlos, Madrid, Spain

Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling

Phase 2

Completed

Conditions: Alopecia
Breast Cancer

Interventions: Device: elasto-gel cap

First Posted Date: 2007-08-14

Last Posted Date: 2011-08-09

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 150

Registration Number: NCT00515762

Locations: 🇪🇸
Hospital Clinico San Carlos, Madrid, Spain

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Phase 2

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Capecitabine

First Posted Date: 2007-01-04

Last Posted Date: 2019-02-22

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 195

Registration Number: NCT00418028

Locations: 🇪🇸
Hospital Clinico San Carlos, Madrid, Spain

Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: doxorubicin
Drug: docetaxel

First Posted Date: 2005-07-26

Last Posted Date: 2009-08-06

Lead Sponsor: Hospital San Carlos, Madrid

Target Recruit Count: 250

Registration Number: NCT00123929

Locations: 🇪🇸
Servicio de Oncologia Medica, Hospital Clinico San Carlos, Madrid, Spain

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy